CVS Caremark

When the Federal Trade Commission (FTC) officially accused the three largest PBMs of artificially inflating insulin prices, it marked the latest move in what has become a protracted effort by federa

A just-filed Federal Trade Commission legal action against pharmacy benefit managers CVS Caremark , Express Scripts and OptumRx and their group purchasing organizations for insulin rebating pract

Madrigal Pharmaceuticals, Inc. reported $14.6m in second quarter US sales revenue for Rezdiffra (resmetirom) on 7 August, which the company and analysts both described as a solid early launch for the

Top executives at the three largest pharmacy benefit managers largely stuck to the script despite bipartisan skepticism and the growing frustration of the House Oversight and Accountability Committee